// App-Quantinova.ai

178 : No Escalation of Therapy Despite High Disease Activity in the CATCH Cohort

Researchers

Presenter

  • Cheryl Barnabe

Principal Investigators

  • Gilles Boire

  • Carol Hitchon

  • Ed Keystone

  • Boulos Haraoui

  • Carter Thorne

  • Diane Tin

  • Janet Pope

  • Vivian Bykerk

Medical Centers

  • University of Western Ontario, St Joseph's Health Care, London,Canada

  • Univ of Calgary, Calgary, Canada

  • Univ of Manitoba, Winnipeg, Canada

  • Institut de Rhumatologie, Montreal, QC, Canada

  • St Michael's Hospital, University of Toronto, Toronto, ON, Canada

  • Hospital for Special Surgery, New York, NY.

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Malondialdehyde

  • Albumin/creatinine

Drug/Treatment

  • Methotrexate

Outcome

  • Unknown


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim